Gsk Share Discussion Threads

[sat69] 02/6/2009 07:39

Certainly looks like heading back to £10 - Doesn't make sense to me

[gotnorolex] 01/6/2009 10:35

PreMarket up in the US at the moment...up 1.13% from friday's close!

[captain kurt] 01/6/2009 10:16

Keep the faith...looking good in the US

[rikclay] 01/6/2009 09:49

sold out...this share is going nowhere...only down

[gotnorolex] 30/5/2009 16:26

Here is what Jim Cramer of MadMoney said of GSK (closed 33.71 (+0.63%) "Too boring for me,"......Well he doesn't think it offers any upside from here! I'm happy to sit tight and collect regular divis from this tortoise!

[eisler] 29/5/2009 15:27

When it hits 1000, get in! Though not holding my breath - perhaps tonight's FDA announcement may push share price higher next week.

[lurnin] 29/5/2009 14:38

The Australian government has bought an additional 1.6 million courses of GlaxoSmithKline's Relenza treatment for pandemic flu.
And still it go's down , once they have sorted the tax prob out could be a coiled spring effect (on the upward bounce of course )

[parvo] 28/5/2009 20:21

Influenza virus is an RNA virus and therefore continually makes bad copy or mutation. It is likely that the new vaccine will give some protection even if the virus changes a bit. This is why we have a new vaccine very year; a different one for southern hemisphere and northern hemisphere.

[frizsand] 28/5/2009 19:54

GSK mentioned

[sat69] 28/5/2009 18:41

Interesting point Lurnin. I guess the big boys have weighed up all the pros and cons and don't feel it'll significantly affect the GSK bottom line, otherwise the share price would have been over £12 by now.

[lurnin] 28/5/2009 18:29

Am i right in thinking that , if the h1n1 virus mutates and changes it's dna make up, the present vaccination will be deemed ineffective , and that GSK will have to identify new dna and then manufacture another sixty million doses , and then if it once again mut!!!!!!! it seems it could be never ending it's gotta be good for the share price surely .

[sat69] 28/5/2009 18:09

USA now have had 10 deaths - ww cases neary 14,000. Amazing this has had virtually no effect on GSK or the markets.

[gotnorolex] 28/5/2009 16:42

BBC Breaking News.......5:40pm
"Eton closes school for one week to contain Swine Flu"

[gotnorolex] 28/5/2009 10:16

Becoming a slow but steady momentum stock!

[sportbilly1976] 26/5/2009 10:14

seems to be rather range-bound at the moment.....will wait till it break the blue line until I consider a position..

[captain kurt] 26/5/2009 08:11

26 May 2009
Open A Buy Bet In June GlaxoSmithKline

Says TopSpreadBets.com

The Bet: We recommended opening a buy bet in June GlaxoSmithkline (GSK) (Expiry June 16th) to TopSpreadBet.com subscribers at £10 a penny when the quote was standing at 1,038p - 1,040p. It is now 1,055p - 1057p and we still think this is a bet worth taking. The target is 1,300p and the stop loss at 979p for a risk of £780 at our suggested wager.

The Fundamental View: We were opening a buy bet in June GlaxoSmithkline on the basis that defensive stocks such as the drugs giant are likely to come back into play after the recent stock market rally. But we said that the attractions of Glaxo are its steady performance in a crisis, and the latest swine flu epidemic seems to have brought the market to focus on the company's anti viral drug Relenza. How far the scare will push up the shares is still in doubt, but it would appear to be enough to stabilise sentiment towards the shares.

Last week ING upgraded its stance on GlaxoSmithKline to hold from sell after a a 19% fall in the share price since January. Elsewhere, it says emerging market growth coupled with cost savings should support modest EPS growth post '09 and thinks this justifies the current earnings multiple. Furthermore, it adds that pipeline expectations are low so any positive research and development could potentially drive upside valuations.

Open a buy bet in June GlaxoSmithKline as swine flu fears are likely to underpin sentiment towards the stock and the fundamentals are attractive.

The Technical View: We were looking at a charting buy here for GlaxoSmithkline on the basis of multiple support for the shares at or just below the £10 level since the autumn. While this does not guarantee support will be permanent, to go into a buy bet at current levels with a stop loss at 979p should be a decent prospect. The top of the 6 month range at 1,300p is the eventual target.



Conclusion: Open a buy bet in June GlaxoSmithkline open on the basis that swine flu has given the stock a new positive momentum

[gotnorolex] 26/5/2009 07:44

Just topped up on the dip......so there!

[grahamite2] 26/5/2009 07:23

Er, monty, when you're short you normally go for 935 as your scare story don't you?

[oneeyedjack01] 26/5/2009 07:20

Monty how can you go from uber bull to uber bear and expect anyone to take you seriously? On my filter list you go. I nearly sold out the other day but ended up holding as I waited to try and get a touch more on my CFD. I am still holding and my thoughts are still the same, this should go up, sector rotation ought to be kicking in. I shall keep my patience for a little longer.

[648790] 23/5/2009 13:51

oh shut up slave!

[sat69] 23/5/2009 13:49

We know you've sold out now Monty! :-)

[montyhedge] 23/5/2009 13:02

Tax issue going to depressed share price for quite sometimne, I see 950p coming.

[sat69] 23/5/2009 12:14

FT front page - WHO backs down over sf assessment. Also, ADR's close lower on Friday. All points to a revisit of £10 in the short term.